Reckitt Benckiser(US:RBGLY) Prnewswireยท2025-06-27 13:00Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that affected investors between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Allegations - The lawsuit claims that Reckitt's cow's milk-based formula, Enfamil, increased the risk of preterm infants developing NEC, which was not disclosed [2]. - It is alleged that the company concealed the impact of these risks on Enfamil's sales and its exposure to legal claims [2]. - Positive statements made by the defendants regarding the company's business and prospects were claimed to be materially false and misleading [2]. Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]. - The firm has over 70 employees dedicated to serving clients in complex securities litigation [4].